VIMTA LABS
Back to Cashflow Statement
|
VIMTA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.90 Cr | ₹-11 Cr | ₹-17 Cr | ₹-4.57 Cr | ₹-0.67 Cr |
What is the latest Cash Flow from Financing Activities ratio of VIMTA LABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2024 | ₹-1.90 Cr |
| Mar2023 | ₹-11 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-4.57 Cr |
| Mar2020 | ₹-0.67 Cr |
How is Cash Flow from Financing Activities of VIMTA LABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹-1.90 Cr | Negative | |
| Mar2023 | ₹-11 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-4.57 Cr | Negative | |
| Mar2020 | ₹-0.67 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,800.2 Cr | -2.7% | -9.2% | 72.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,171.0 Cr | 2.8% | 6.6% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -0.2% | -0.7% | 10.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | -0.2% | 8.1% | 21.8% | Stock Analytics | |
| CIPLA | ₹124,094.0 Cr | 1.4% | -1.4% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 2.7% | 1% | -3.4% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -2.7% |
-9.2% |
72.4% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses